Eli Lilly and Company (LLY) vs The Procter & Gamble Company (PG)

See how Eli Lilly and Company and The Procter & Gamble Company differ across market data and performance, so you can decide which asset best fits your strategy.

$1,210.89
NYSE
Eli Lilly & Co. is a pharmaceutical company focused on neuroscience, cardiometabolic disease, oncology, and immunology. Its leading products include Verzenio and Jaypirca in cancer treatment; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin in cardiometabolic care; and Taltz and Olumiant in immunology.
View Full Page
$156.28
NYSE
Founded in 1837, Procter & Gamble Company (PG) has grown into one of the world’s largest consumer goods manufacturers, generating nearly $85 billion in annual sales. Its portfolio includes many leading brands, with more than 20 producing over $1 billion in global annual revenue each, including Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. International markets account for slightly more than half of the company’s consolidated sales.
View Full Page

Key Metrics Comparison

Eli Lilly and CompanyLLY
Market Cap
$1.079T
Price
$1,210.89
24h Change
+3.80%
24h Volume
$1.89M
Employees
50,000
Shares Outstanding
944,818,881
The Procter & Gamble CompanyPG
Market Cap
$363.262B
Price
$156.28
24h Change
+2.12%
24h Volume
$5.27M
Employees
109,000
Shares Outstanding
2,328,598,978

Category Performance

Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.

Market Share

Share of combined market cap

Market Share
LLY
74.8%
PG
25.2%

Volume Share

Share of combined 24h volume

Volume Share
LLY
26.4%
PG
73.6%

24h Performance

Price change over last 24 hours

24h Performance
LLY
3.80%
PG
2.12%
Price Comparison
Eli Lilly and Company
The Procter & Gamble Company